Anti-DHRS2 antibody (1-300) (STJ28529)

SKU:
STJ28529
£110.50 - £505.50
Free Shipping
Processing The item has been added

Short Description :Rabbit polyclonal DHRS2 (1-300) antibody for use in WB, IF, ICC and ELISA in human, mouse and rat samples. Datasheet included with dilution recommendations, and related reagents.
Applications:WB/IF/ICC/ELISA
Host:Rabbit
Reactivity:Human/Mouse/Rat
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Polyclonal
Isotype:IgG
Conjugation:Unconjugated
Concentration:Lot specific
Purification:Affinity purification
Dilution Range:WB:1:500-1:1000
IF/ICC:1:10-1:100
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Formulation:PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3.
Storage Instruction:Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol:DHRS2
Gene ID:10202
Uniprot ID:DHRS2_HUMAN
Immunogen Region:1-300
Immunogen Sequence:MLSAVARGYQGWFHPCARLS VRMSSTGIDRKGVLANRVAV VTGSTSGIGFAIARRLARDG AHVVISSRKQQNVDRAMAKL QGEGLSVAGIVCHVGKAEDR EQLVAKALEHCGGVDFLVCS AGVNPLVGSTLGTSEQIWDK ILSVNVKSPALLLSQLLPYM ENRRGAVILVSSIAAYNPVV ALGVYNVSKTALLGLTRTLA LELAPKDIRVNCVVPGIIKT DFSKVVRIGFMGMSLSGRT
Specificity:Recombinant fusion protein containing a sequence corresponding to amino acids 1-300 of human DHRS2 (NP_878912.1).
Tissue Specificity Widely expressed, with highest levels in liver and kidney, followed by heart, spleen, skeletal muscle and placenta. In hemopoietic cells, expressed in dendritic cells, but not in monocytes, macrophages, granulocytes, nor in B and T lymphocytes.
Function NADPH-dependent oxidoreductase which catalyzes the reduction of dicarbonyl compounds. Displays reductase activity in vitro with 3,4-hexanedione, 2,3-heptanedione and 1-phenyl-1,2-propanedione as substrates. May function as a dicarbonyl reductase in the enzymatic inactivation of reactive carbonyls involved in covalent modification of cellular components. Also displays a minor hydroxysteroid dehydrogenase activity toward bile acids such as ursodeoxycholic acid (UDCA) and isoursodeoxycholic acid (isoUDCA), which makes it unlikely to control hormone levels. Doesn't show any activity in vitro with retinoids and sugars as substrates. Attenuates MDM2-mediated p53/TP53 degradation, leading to p53/TP53 stabilization and increased transcription activity, resulting in the accumulation of MDM2 and CDKN1A/p21. Reduces proliferation, migration and invasion of cancer cells and well as the production of ROS in cancer.
Protein Name Dehydrogenase/Reductase Sdr Family Member 2 - Mitochondrial
Dicarbonyl Reductase Hep27
Protein D
Short Chain Dehydrogenase/Reductase Family 25c Member 1
Protein Sdr25c1
Database Links
Cellular Localisation Mitochondrion Matrix
Nucleus
A Minor Fraction Of The Protein Is Translocated From The Mitochondria To The Nucleus
After Cleavage Of The Targeting Signal
Alternative Antibody Names Anti-Dehydrogenase/Reductase Sdr Family Member 2 - Mitochondrial antibody
Anti-Dicarbonyl Reductase Hep27 antibody
Anti-Protein D antibody
Anti-Short Chain Dehydrogenase/Reductase Family 25c Member 1 antibody
Anti-Protein Sdr25c1 antibody
Anti-DHRS2 antibody
Anti-SDR25C1 antibody

Information sourced from Uniprot.org